Vertex Pharmaceuticals (VRTX) Assets (2016 - 2025)
Historic Assets for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to $24.9 billion.
- Vertex Pharmaceuticals' Assets rose 1178.99% to $24.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 billion, marking a year-over-year increase of 1178.99%. This contributed to the annual value of $22.5 billion for FY2024, which is 86.67% down from last year.
- According to the latest figures from Q3 2025, Vertex Pharmaceuticals' Assets is $24.9 billion, which was up 1178.99% from $24.0 billion recorded in Q2 2025.
- In the past 5 years, Vertex Pharmaceuticals' Assets ranged from a high of $24.9 billion in Q3 2025 and a low of $12.1 billion during Q1 2021
- In the last 5 years, Vertex Pharmaceuticals' Assets had a median value of $20.1 billion in 2024 and averaged $18.9 billion.
- Per our database at Business Quant, Vertex Pharmaceuticals' Assets soared by 3622.83% in 2021 and then plummeted by 433.53% in 2025.
- Vertex Pharmaceuticals' Assets (Quarter) stood at $13.4 billion in 2021, then soared by 35.13% to $18.2 billion in 2022, then increased by 25.23% to $22.7 billion in 2023, then decreased by 0.87% to $22.5 billion in 2024, then rose by 10.34% to $24.9 billion in 2025.
- Its Assets was $24.9 billion in Q3 2025, compared to $24.0 billion in Q2 2025 and $22.9 billion in Q1 2025.